🟢 20/20 Biolabs is trading 10.69% up today as in-line July CPI eased hike expectations

20/20 Biolabs is trading 10.69% up at $0.48, with broader risk-on sentiment following in-line July CPI and reduced interest-rate-hike expectations.

• The Nasdaq Composite is up 0.75%, exceeding the 0.5% threshold for meaningful market context, as technology shares strengthened.
• No clearly reported company-specific announcement was identified on August 12, 2026; recent materials cover earlier webinars and commercial progress.
• Trading remains active during the open session; confidence is medium because company-specific reporting is limited.